title: The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.
abstract: BACKGROUND
  Neuroendocrine tumors (NETs) of the esophagus are extremely rare, and few cases have been reported worldwide. Thus, a comprehensive nationwide study is needed to understand the characteristics of and treatment strategy for esophageal NETs.
  
  
  METHODS
  We collected data on esophageal NET patients from 25 hospitals in Korea from 2002-2012. The incidence, location, clinical symptoms, histopathology, treatment response, and the biochemical, radiologic and endoscopic characteristics of esophageal NETs were surveyed.
  
  
  RESULTS
  Among 2,037 NETs arising in different gastrointestinal sites, esophageal NETs were found in 26 cases (1.3%). The mean patient age was 60.12 ± 9.30 years with a 4:1 male predominance. In endoscopic findings, 76.9% (20/26) of NETs were located in the lower third of the esophagus and the mean size was 2.34 ± 1.63 cm. At diagnosis, more than half the patients (15/26, 57.7%) had regional lymph node metastasis or widespread metastasis. Endoscopic resection was conducted in three cases, and in all three of them, lymph node metastasis was not found and tumor size was below 1.0 cm. All tumors were completely removable through endoscopic procedures and there was no recurrence during the follow-up period. Eighteen other patients received an operation, chemotherapy or both. Among them, nine patients (50.0%) expired because of the progression of their cancer or post-operative complications. In Kaplan-Meier survival analysis, only tumor size (more than 2.0 cm) showed prognostic significance (P = 0.045).
  
  
  CONCLUSIONS
  Despite the general assumption that gastrointestinal NETs are benign and slow-growing tumors, the prognosis of advanced esophageal NETs is not favorable.
authors.forename: Chang Geun
authors.initials: CG
authors.lastname: Lee
authors.affiliation: Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University-Seoul, Graduate School of Medicine, Goyang, Korea. limyj@dongguk.ac.kr.
authors.forename: Yun Jeong
authors.initials: YJ
authors.lastname: Lim
authors.forename: Seun Ja
authors.initials: SJ
authors.lastname: Park
authors.forename: Byung Ik
authors.initials: BI
authors.lastname: Jang
authors.forename: Seok Reyol
authors.initials: SR
authors.lastname: Choi
authors.forename: Jae Kwang
authors.initials: JK
authors.lastname: Kim
authors.forename: Yong-Tae
authors.initials: YT
authors.lastname: Kim
authors.forename: Joo Young
authors.initials: JY
authors.lastname: Cho
authors.forename: Chang Hun
authors.initials: CH
authors.lastname: Yang
authors.forename: Hoon Jai
authors.initials: HJ
authors.lastname: Chun
authors.forename: Si Young
authors.initials: SY
authors.lastname: Song
mesh_terms: D000368:Aged; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy*; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D018358:Neuroendocrine Tumors / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy*; D011379:Prognosis; D056910:Republic of Korea / Q000453:epidemiology
references.citation: Nihon Geka Gakkai Zasshi. 2008 May;109(3):147-51
references.pmid: 18536318
references.citation: Am J Gastroenterol. 2004 Sep;99(9):1801-6
references.pmid: 15330922
references.citation: Tumori. 2010 Sep-Oct;96(5):780-3
references.pmid: 21302629
references.citation: Am J Surg Pathol. 2002 Apr;26(4):517-22
references.pmid: 11914632
references.citation: Ann Surg. 1999 Jun;229(6):815-21; discussion 822-3
references.pmid: 10363895
references.citation: Am J Surg Pathol. 2013 Apr;37(4):467-83
references.pmid: 23426118
references.citation: Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):195-208
references.pmid: 23731881
references.citation: Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):491-505
references.pmid: 16183523
references.citation: Ann N Y Acad Sci. 2004 Apr;1014:13-27
references.pmid: 15153416
references.citation: Cancer. 1997 Feb 15;79(4):813-29
references.pmid: 9024720
references.citation: World J Surg. 2005 Jan;29(1):92-101
references.pmid: 15599742
references.citation: Dig Dis Sci. 1990 Jan;35(1):145-52
references.pmid: 2153068
references.citation: Clinics (Sao Paulo). 2011;66(10):1671-5
references.pmid: 22012036
references.citation: Obes Rev. 2012 May;13(5):469-79
references.pmid: 22188520
references.citation: Hum Pathol. 1999 Feb;30(2):216-21
references.pmid: 10029452
references.citation: Dtsch Med Wochenschr. 2010 Jan;135(1-2):19-21
references.pmid: 20024878
references.citation: Am J Surg Pathol. 2008 Sep;32(9):1404-11
references.pmid: 18670347
references.citation: Histopathology. 1987 Jan;11(1):53-62
references.pmid: 2881873
references.citation: BMC Cancer. 2007 Mar 03;7:38
references.pmid: 17335582
references.citation: Am J Gastroenterol. 2004 Sep;99(9):1807-14
references.pmid: 15330923
references.citation: Am J Clin Oncol. 2000 Oct;23(5):455-9
references.pmid: 11039503
references.citation: Int J Clin Exp Pathol. 2013;6(3):485-91
references.pmid: 23411580
references.citation: Cancer Res Treat. 2012 Sep;44(3):157-65
references.pmid: 23091441
references.citation: Lancet Oncol. 2006 Nov;7(11):891
references.pmid: 17099980